SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-015620
Filing Date
2021-08-05
Accepted
2021-08-04 18:03:47
Documents
67
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aeri-20210630.htm   iXBRL 10-Q 1353324
2 EX-31.1 aeri6302021ex311.htm EX-31.1 12472
3 EX-31.2 aeri6302021ex312.htm EX-31.2 12477
4 EX-32.1 aeri6302021ex321.htm EX-32.1 7316
5 EX-32.2 aeri6302021ex322.htm EX-32.2 7277
11 aeri-20210630_g1.jpg GRAPHIC 13447
12 aeri-20210630_g2.jpg GRAPHIC 13674
  Complete submission text file 0001628280-21-015620.txt   6241277

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeri-20210630.xsd EX-101.SCH 38469
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aeri-20210630_cal.xml EX-101.CAL 65035
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeri-20210630_def.xml EX-101.DEF 204037
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeri-20210630_lab.xml EX-101.LAB 520852
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeri-20210630_pre.xml EX-101.PRE 340825
13 EXTRACTED XBRL INSTANCE DOCUMENT aeri-20210630_htm.xml XML 1073756
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 211145458
SIC: 2836 Biological Products, (No Diagnostic Substances)